Evolent Health, Inc. (EVH)

USD 10.69

(7.44%)

Long Term Debt Summary of Evolent Health, Inc.

  • Evolent Health, Inc.'s latest annual long term debt in 2023 was 635.05 Million USD , up 35.41% from previous year.
  • Evolent Health, Inc.'s latest quarterly long term debt in 2024 Q2 was 782.99 Million USD , down -19.2% from previous quarter.
  • Evolent Health, Inc. reported annual long term debt of 468.99 Million USD in 2022, up 71.54% from previous year.
  • Evolent Health, Inc. reported annual long term debt of 273.39 Million USD in 2021, down -16.1% from previous year.
  • Evolent Health, Inc. reported quarterly long term debt of 782.99 Million USD for 2024 Q2, down -19.2% from previous quarter.
  • Evolent Health, Inc. reported quarterly long term debt of 635.05 Million USD for 2023 Q4, down -0.71% from previous quarter.

Annual Long Term Debt Chart of Evolent Health, Inc. (2023 - 2012)

Historical Annual Long Term Debt of Evolent Health, Inc. (2023 - 2012)

Year Long Term Debt Long Term Debt Growth
2023 635.05 Million USD 35.41%
2022 468.99 Million USD 71.54%
2021 273.39 Million USD -16.1%
2020 325.86 Million USD -10.11%
2019 362.52 Million USD 64.01%
2018 221.04 Million USD 82.09%
2017 121.39 Million USD 0.92%
2016 120.28 Million USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%

Peer Long Term Debt Comparison of Evolent Health, Inc.

Name Long Term Debt Long Term Debt Difference
American Well Corporation 8.2 Million USD -7638.947%
Doximity, Inc. 12.39 Million USD -5022.675%
MultiPlan Corporation 4.53 Billion USD 85.989%
Phreesia, Inc. 2.04 Million USD -30893.558%
Teladoc Health, Inc. 1.58 Billion USD 59.845%
Veeva Systems Inc. 46.44 Million USD -1267.451%